ArticleInternational journal of women's health2026
Epidemiological Risk Factor Analysis for Maternal Mortality Associated with Eclampsia: A Single-Center Study from Tertiary Hospital Garut.
Article in International journal of women's health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Maternal mortality remains a major global health challenge, particularly in low- and middle-income countries. Eclampsia, a severe complication of hypertensive disorders in pregnancy, continues to contribute substantially to maternal and perinatal deaths despite advances in obstetric care. Previous studies have highlighted the role of clinical and laboratory abnormalities in worsening outcomes; however, evidence from developing settings remains limited. A clearer understanding of maternal mortality risk factors in eclampsia is essential to improve early detection, risk stratification, and clinical management. Objective: To identify maternal mortality risk factors associated with eclampsia based on patient characteristics, clinical presentation, and laboratory findings. Methods: A retrospective observational study was conducted using medical records of pregnant women diagnosed with eclampsia between January 2022 and March 2024 at a tertiary referral hospital. Demographic data, clinical features, and laboratory parameters were extracted systematically. Statistical analysis included univariate and bivariate analyses using the Chi-square test to assess associations between variables and maternal mortality. Multivariate logistic regression analysis was performed to determine independent risk factors and estimate odds ratios (OR) with corresponding p-values. Statistical significance was set at p ≤ 0.05. Results: A total of 112 patients met the inclusion criteria. The eclampsia case fatality rate was 20.54%. Laboratory parameters demonstrated significant associations with maternal mortality. Severe proteinuria (+3) was associated with increased mortality risk (OR = 1.67; p = 0.05). Anemia, defined as hematocrit <35%, showed a strong association with maternal death (OR = 2.25; p = 0.001). Additionally, HELLP syndrome significantly increased the risk of maternal mortality (OR = 2.82). Conclusion: Laboratory abnormalities are key predictors of maternal mortality in eclampsia. Severe proteinuria, anemia, and HELLP syndrome should be promptly identified and managed to reduce adverse maternal outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.